{
    "Trade/Device Name(s)": [
        "SASTM Influenza A Test",
        "SASTM FluAlert A & B Test",
        "SAS\u2122 Influenza A",
        "SAS\u2122 FluAlert A & B"
    ],
    "Submitter Information": "SA Scientific, Ltd.",
    "510(k) Number": "K132352",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "July 22, 2013",
    "Summary Letter Received Date": "August 2, 2013",
    "Submission Date": "July 22, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal washes",
        "Nasal aspirates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Visual rapid assay"
    ],
    "Methodologies": [
        "Antigen detection",
        "Sandwich immunocomplex formation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for SASTM Influenza A Test and SASTM FluAlert A & B Test\u2014rapid visual immunochromatographic assays for detection of influenza A and B antigens from nasal samples.",
    "Indications for Use Summary": "Presumptive in-vitro qualitative detection of Influenza A and/or Influenza B viral nucleoprotein antigens from nasal washes and nasal aspirates of symptomatic patients; not intended for detection of Influenza Type C antigen; for professional use only; negative results should be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}